Safety in numbers-monitoring risk in approved drugs

Article Abstract:

Drug-policy experts, lawmakers, consumer advocates, and federal officials are all working for better ways of monitoring drug safety, since the Food and Drug Administration (FDA) carries out a speedy review of product applications, resulting in more than 60 percent of new drugs approved first in the United States. The urgency of this effort is clear, since more Americans are taking prescription medications than ever before.

United States, General services, Pharmaceutical preparations, Safety and security measures, Pharmaceutical industry, United States. Food and Drug Administration, Drug approval

---

New York to Trans fats: You're out!

Article Abstract:

The New York City Board of Health would not permit to use more than half a gram per serving of artificial Trans fats by July 1, 2007. Banishing artificial Trans fat from restaurant foods would reduce the rate of heart attacks and save the lives of several hundred New Yorkers annually.

Government domestic functions, FOOD AND KINDRED PRODUCTS, New York, Health aspects, Interpretation and construction, Food industry, Health policy, Food and beverage production/distribution software, Public health law, Trans fatty acids, New York, New York. Board of Health

---

Similar abstracts:

• Abstracts: Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York state expanded syringe access demonstration program
• Abstracts: Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk satisfaction. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
• Abstracts: Federal funding and supportive policies for research. Responses of medical schools to institutional conflicts of interest
• Abstracts: MRI reveals gene activity in vivo. Genomics proving a powerful tool for mapping the landscape of the brain. Pain studies illuminate placebo effect
• Abstracts: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.